Two Sigma Advisers’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $887K | Buy |
454,900
+96,100
| +27% | +$187K | ﹤0.01% | 1504 |
|
|
2025
Q1 | $631K | Sell |
358,800
-117,600
| -25% | -$207K | ﹤0.01% | 1679 |
|
|
2024
Q4 | $1.27M | Sell |
476,400
-57,500
| -11% | -$153K | ﹤0.01% | 1352 |
|
|
2024
Q3 | $1.22M | Sell |
533,900
-211,900
| -28% | -$485K | ﹤0.01% | 1318 |
|
|
2024
Q2 | $2.18M | Sell |
745,800
-272,800
| -27% | -$797K | ﹤0.01% | 1146 |
|
|
2024
Q1 | $3.71M | Sell |
1,018,600
-128,300
| -11% | -$467K | 0.01% | 914 |
|
|
2023
Q4 | $1.73M | Buy |
1,146,900
+412,200
| +56% | +$622K | ﹤0.01% | 1371 |
|
|
2023
Q3 | $984K | Buy |
734,700
+79,500
| +12% | +$107K | ﹤0.01% | 1528 |
|
|
2023
Q2 | $1.18M | Buy |
655,200
+27,000
| +4% | +$48.6K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $1.04M | Sell |
628,200
-73,500
| -10% | -$122K | ﹤0.01% | 1609 |
|
|
2022
Q4 | $1.35M | Buy |
701,700
+319,500
| +84% | +$613K | ﹤0.01% | 1427 |
|
|
2022
Q3 | $856K | Buy |
382,200
+263,500
| +222% | +$590K | ﹤0.01% | 1595 |
|
|
2022
Q2 | $385K | Buy |
118,700
+97,000
| +447% | +$315K | ﹤0.01% | 2035 |
|
|
2022
Q1 | $114K | Buy |
+21,700
| New | +$114K | ﹤0.01% | 2484 |
|